Document is current
Any future updates will be listed below
-
Authors
Wu, Man https://orcid.org/0009-0005-5638-0131
Hau, Pok Man
Li, Linxian
Tsang, Chi Man https://orcid.org/0000-0001-6817-4590
Yang, Yike https://orcid.org/0000-0001-8256-6865
Taghbalout, Aziz
Chung, Grace Tin-Yun
Hui, Shin Yee https://orcid.org/0009-0003-2934-9820
Tang, Wing Chung
Jillette, Nathaniel
Zhu, Jacqueline Jufen https://orcid.org/0000-0001-6416-4563
Lee, Horace Hok Yeung
Kong, Ee Ling
Chan, Melissa Sue Ann
Chan, Jason Ying Kuen https://orcid.org/0000-0002-9480-4637
Ma, Brigette Buig Yue https://orcid.org/0000-0003-4802-1102
Chen, Mei-Ru
Lee, Charles https://orcid.org/0000-0001-7317-6662
To, Ka Fai https://orcid.org/0000-0003-4919-3707
Cheng, Albert Wu https://orcid.org/0000-0003-2653-5743
Lo, Kwok-Wai https://orcid.org/0000-0002-3488-6124
- License Information
-
More Information
Article History
Received: 7 June 2023
Accepted: 17 April 2024
First Online: 3 May 2024
Competing interests
: K.W.L., A.W.C., P.M.H. and M.W. have filed a patent application “Activation of lytic genes in cancer cells” (WO 2021/173977A9; PCT/US2021/019880); K.W.L., M.W., P.M.H. and C.M.T. have filed a US provisional patent application, “Synthetic mRNAs for treatment of EBV-associated diseases” (no. 63/462,197). K.W.L., C.M.T. and M.W. are cofounders of ACE NanoMed Ltd. K.W.L. received research funding from Viracta Therapeutics and ScinnoHub Pharmaceutical Co., Ltd. B.Y.Y.M. is a consultant for Viracta Therapeutics, Alentis and Y-biologics, serves on the advisory boards of MSD, BMS, Novartis and Taiho; and has received research funding from Boerhinger Ingelheim and Merck Serono. All other authors declare no competing interests. J.Y.K.C. is cofounder of Agilis Robotics and has received research funding from MSD.
